International Aid Sector Under Pressure to Reform as Overhead Costs Face Scrutiny UN Raises Ebola Risk Level to Very High in DR Congo Potential Implications for Regional Markets Smaller Robotaxi Challenger Posts Nearly 400 Revenue Growth Dwarfing Tesla in Segment SP 500 Hits Fresh High as Healthcare and Tech Lead Gains Workday Stock Rises on Upgraded Margin Outlook AI Initiatives Show Promise Asian Markets Rally as Wall Street Hits New Highs Oil Prices Retreat GIB Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher SUI Q1 2026 Earnings Misses EPS Estimates with Surprise Loss Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS on Trust Earnings Amid Continued Search for Merger Target Star Group LP SGU Q1 2026 Earnings Strong EPS of 266 Driven by Winter Heating Demand Cadiz Inc Depositary Shares CDZIP Q1 2026 Earnings Narrower Loss Than Expected Amid Water Operations MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates on Strong Core Performance Arrow Financial Corporation AROW Edges Lower Amid Broader Sector Weakness Oculis Holding OCS Slips 487 as Shares Test Key Support Zone Docebo DCBO Slips Testing Key Support Levels Amid Market Headwinds TryHard Holdings THH Surges 34 Key Levels and Market Dynamics BlackRock Science and Technology Term Trust BSTZ Rises 113 as Tech Sentiment Improves Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Hurdles WRLD Q1 2026 Earnings EPS Misses Estimates Amid Mixed Credit Trends Stock Edges Higher Nutriband Inc Warrant NTRBW Plunges Nearly 20 Key Levels to Watch My Size Inc MYSZ Q4 2025 Earnings Large EPS Miss Overshadowed by Modest Stock Gain NUTX Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 932 Lantheus Q1 2026 Earnings Strong EPS Beat Driven by Radiopharmaceutical Momentum PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter Energy Recovery Inc Q1 2026 Earnings EPS Misses Estimates as Stock Gains 267 NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines